Rabbit Polyclonal POLR1A antibody. Suitable for ICC/IF and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human POLR1A aa 800-950.
pH: 7.2
Preservative: 0.02% Sodium azide
Constituents: PBS, 40% Glycerol (glycerin, glycerine)
ICC/IF | |
---|---|
Human | Tested |
Mouse | Predicted |
Rat | Predicted |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 0.25000-2.00000 µg/mL | Notes Fixation/Permeabilization: PFA/Triton X-100. |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info - | Notes - |
Select an associated product type
Catalytic core component of RNA polymerase I (Pol I), a DNA-dependent RNA polymerase which synthesizes ribosomal RNA precursors using the four ribonucleoside triphosphates as substrates. Transcribes 47S pre-rRNAs from multicopy rRNA gene clusters, giving rise to 5.8S, 18S and 28S ribosomal RNAs (PubMed:11250903, PubMed:11283244, PubMed:16858408, PubMed:34671025, PubMed:34887565, PubMed:36271492). Pol I-mediated transcription cycle proceeds through transcription initiation, transcription elongation and transcription termination stages. During transcription initiation, Pol I pre-initiation complex (PIC) is recruited by the selectivity factor 1 (SL1/TIF-IB) complex bound to the core promoter that precedes an rDNA repeat unit. The PIC assembly bends the promoter favoring the formation of the transcription bubble and promoter escape. Once the polymerase has escaped from the promoter it enters the elongation phase during which RNA is actively polymerized, based on complementarity with the template DNA strand. Highly processive, assembles in structures referred to as 'Miller trees' where many elongating Pol I complexes queue and transcribe the same rDNA coding regions. At terminator sequences downstream of the rDNA gene, PTRF interacts with Pol I and halts Pol I transcription leading to the release of the RNA transcript and polymerase from the DNA (PubMed:11250903, PubMed:11283244, PubMed:16858408, PubMed:34671025, PubMed:34887565, PubMed:36271492). Forms Pol I active center together with the second largest subunit POLR1B/RPA2. Appends one nucleotide at a time to the 3' end of the nascent RNA, with POLR1A/RPA1 contributing a Mg(2+)-coordinating DxDGD motif, and POLR1B/RPA2 participating in the coordination of a second Mg(2+) ion and providing lysine residues believed to facilitate Watson-Crick base pairing between the incoming nucleotide and the template base. Typically, Mg(2+) ions direct a 5' nucleoside triphosphate to form a phosphodiester bond with the 3' hydroxyl of the preceding nucleotide of the nascent RNA, with the elimination of pyrophosphate. Has proofreading activity: Pauses and backtracks to allow the cleavage of a missincorporated nucleotide via POLR1H/RPA12. High Pol I processivity is associated with decreased transcription fidelity (By similarity) (PubMed:11250903, PubMed:11283244, PubMed:16858408, PubMed:34671025, PubMed:34887565, PubMed:36271492).
DNA-directed RNA polymerase I subunit RPA1, RNA polymerase I subunit A1, A190, DNA-directed RNA polymerase I largest subunit, DNA-directed RNA polymerase I subunit A, RNA polymerase I 194 kDa subunit, RPA194, POLR1A
Rabbit Polyclonal POLR1A antibody. Suitable for ICC/IF and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human POLR1A aa 800-950.
pH: 7.2
Preservative: 0.02% Sodium azide
Constituents: PBS, 40% Glycerol (glycerin, glycerine)
The POLR1A protein also known as RNA polymerase I subunit RPA1 plays an important mechanical role in the synthesis of ribosomal RNA (rRNA). POLR1A has a molecular mass of approximately 194 kDa. This protein is ubiquitously expressed across various tissues contributing extensively to the cellular machinery for protein synthesis. As an essential component of RNA polymerase I POLR1A shares structural features typical of RNA polymerase enzymes facilitating the transcription of rRNA genes.
POLR1A functions as part of the RNA polymerase I complex which specializes in transcribing rRNA a critical component of ribosome biogenesis. This process is central to the synthesis of rRNA precursors which later modify to form mature rRNA. POLR1A works in conjunction with other subunits to ensure efficient and accurate transcription within the nucleolus demonstrating its significance in maintaining cellular protein synthesis capacity. The protein's activity supports the assembly of ribosomes influencing cell growth and division.
POLR1A is integrally involved in the ribosome biogenesis and rRNA transcription pathways. These pathways are essential for producing ribosomes the molecular machines responsible for protein translation in cells. POLR1A has interactions with proteins like TIF-IA and UBF both of which regulate its transcriptional activity at specific rRNA gene promoters. This interaction regulates POLR1A's function in response to cellular conditions ensuring that protein synthesis matches cellular demands.
POLR1A's function has links to conditions like Treacher Collins syndrome and Acrofacial Dysostosis. Mutations in POLR1A can lead to defects in ribosome biogenesis disrupting the growth and development of craniofacial structures observed in these syndromes. Additionally POLR1A interacts with proteins such as NOP56 and fibrillarin which are involved in rRNA processing and assembly suggesting that any disruptions in these interactions could contribute to ribosomopathies. POLR1A's role in maintaining rRNA transcription highlights its significance in preventing defects that translate to broader systemic issues.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
PFA-fixed, Triton X-100 permeabilized U-2 OS (human bone osteosarcoma epithelial cell line) cells stained for POLR1A (green) using ab222065 at 4 μg/ml in ICC/IF.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com